As early as 2021, official government reports have suggested that the Wuhan coronavirus (COVID-19) vaccine harms the immune system, with the potential to cause a new form of COVID-19 vaccine-induced acquired immunodeficiency syndrome (AIDS) among those who have received multiple doses of the vaccine.
At the time, these claims were denied by mainstream media even though there was official data that proved how vaccines harmed the vaccinated. Instead of proving otherwise, many government agencies decided to stop publishing the damning information.
This year, authorities investigated COVID-19 vaccine-induced AIDS and antibody-dependent enhancement (ADE) in secret after researchers across the globe from respected universities admitted that various health issues have been appearing hours, days or even weeks after vaccination.
The authorities named the condition “long vax” to make light of the deadly consequences of vaccination.
Data: Vaccinated people in England and Wales significantly more likely to die compared to the unvaccinated
Official data from the government shows that COVID-19 vaccines have already harmed millions of people and killed others.
Data from the Office of National Statistics in the UK has revealed that for over a year, vaccinated people in England and Wales are significantly more likely to die compared to the unvaccinated population per 100,000 people. (Related: Study: Natural immunity provides better protection against omicron than COVID shots.)
This could explain why the U.K. has been suffering significant excess deaths against the five-year average week after week.
Yet Big Pharma continues to push another round of “boosters,” which can cause harmful side effects like all vaccines targeting coronavirus.
According to the establishment and researchers from Harvard University and Yale University, these include cases of abnormal blood clotting and heart inflammation. Both health issues have been recorded since early 2021, with a huge rise in myocarditis or the inflammation of the heart muscle observed among younger males.
Researchers from Harvard and Yale are now studying what they claim is a newly identified condition: long vax. The scientists are also claiming that the condition’s chronic symptoms resemble the made-up disease “long COVID.”
The “study” materialized due to the quietly announced wider acceptance of the adverse effects of COVID-19 vaccination among the mainstream medical and scientific community.
Dr. Anne Louise Oaklander, a neurologist and researcher at Harvard Medical School, warned that for a doctor, seeing one or two patients with these symptoms might seem like a coincidence. But if they’re seeing as many as 10 or 20 patients, it’s obvious that things are more serious than they appear.
Some researchers claim that long vax is occurring due to an immune system overreaction to the spike protein the body is instructed to make after the mRNA contained in the coronavirus vaccines invade cells in the body.
In the early days of the pandemic, health professionals told the public that the spike protein was “harmless” after they decided to conduct the largest experiment on humankind in history following the emergency use authorization of the Pfizer and Moderna COVID-19 vaccines.
Harlan Krumholz, a cardiologist at Yale University, said that he believes there’s something unusual going on with the alarming side effects. He added that as a scientist, it’s his obligation “to have an open mind and learn if there’s something that can be done.”
Scientific data strongly suggests that the body may produce a second round of antibodies that mistakenly attack healthy cells or bind to angiotensin-converting enzyme 2 (ACE2) receptors, which then causes heart rate fluctuations and blood pressure issues.
Common symptoms include abnormal heart rate, extreme fatigue, headaches and blood pressure fluctuations.
The data suggests that the mainstream scientific establishment now believes mRNA COVID-19 injections cause ADE, and maybe even AIDS. This explains why mRNA technology was never authorized for human use before the coronavirus plandemic.
COVID-19 vaccine-induced AIDS
It’s a common misconception that AIDS is only caused by HIV or that they are the same thing. Acquired immune deficiency syndrome (AIDS) is the term used to describe different potentially life-threatening infections and diseases that happen when the immune system has been severely damaged.
People with AIDS have a greater risk of developing certain cancers and serious infections that often occur only in those with a weak immune system, or would otherwise be mild in people with a healthy, working immune system.
Unfortunately, data has revealed that COVID-19 vaccines should be added to the list of causes.
This confidential data shows that the COVID-19 vaccines shouldn’t have been granted emergency use authorization and that they must be pulled from distribution by the Food and Drug Administration (FDA).
Despite the recorded cases of vaccine-related injuries and deaths, it is promising to see that mainstream media is now investigating the debilitating consequences of COVID-19 vaccination years after what will eventually be considered a “criminal real-world experiment.”
Watch the video above for more about the weaponized COVID-19 vaccine rollout. This video is from the InfoWars channel on Brighteon.com.
More related stories:
- Switzerland stops recommending COVID-19 vaccines, citing population’s high immunity.
- RIGGED: Twitter censored posts about natural immunity and vaccines after pressure from Pfizer board member.
- VAX FOR TAX: Covid vaccines have caused a surge in IRS estate tax revenues as fully vaccinated wealthy people DIE.
Sources include:
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.